NF-kB signaling pathway is often deregulated and its expression is increased in most cancers as it promotes proliferation via increased activation of cytokines and pro-inflammatory genes (Karin and Greten 2005; Xia et al. 2018). The gene discussed is NFKB1; the disease is cancer.